APA način citiranja

Chmielowski, B. (2013). Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma. Hindawi Publishing Corporation.

Čikaški stil citiranja

Chmielowski, Bartosz. Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma. Hindawi Publishing Corporation, 2013.

MLA način citiranja

Chmielowski, Bartosz. Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma. Hindawi Publishing Corporation, 2013.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.